Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Ekaterina Rogaeva × Clear Filters

3 results found

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

Amyotrophic lateral sclerosis (ALS) is a terminal disease that paralyzes people because the brain is no longer able to communicate with the muscles that we are typically able to move at will.


Grant type
Platform grants
Area of Research
Neurodegeneration
Competition
2019 Platform Support Grants
Province
Alberta
Start Date
2021

Modulating the ALS-associated C9orf72 repeat expansion in a murine model for therapeutic benefit

Mutations in a gene called C9ORF72 are the most common genetic cause of ALS. These mutations are unique in that unlike most other ALS-linked genes, where there is often a mistake in a single piece of DNA, C9ORF72 mutations involve a section of DNA that is abnormally repeated hundreds or even thousands of times.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Discovery Grants
Province
Ontario
Start Date
2021

Project MinE

Project MinE is a multi-national initiative with currently participating countries.


Grant type
Platform grants
Area of Research
Neurodegeneration
Competition
Other
Province
Québec
Start Date
2017